CA
ALXN

Commerzbank Aktiengesellschaft’s Alexion Pharmaceuticals ALXN Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-14,800
Closed -$181K – 1063
2019
Q2 		$181K Buy
+14,800
New +$1.91M ﹤0.01% 954

Other funds holding ALXN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Commerzbank Aktiengesellschaft's ALXN Position: Q2 2020 in Review

Commerzbank Aktiengesellschaft sold out of Alexion Pharmaceuticals (ALXN) in Q2 2020, closing a stake of 6,247 shares — an estimated $561K sold.

Commerzbank Aktiengesellschaft first reported a position in ALXN in Q2 2013 and held it in 28 quarters. The position peaked at $23.9M in Q2 2015. 707 funds tracked by Wall St. Rank hold ALXN as of Q2 2020.

  • Commerzbank Aktiengesellschaft reported no remaining Alexion Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 6,247 Alexion Pharmaceuticals shares in Q2 2020, an estimated $561K.
  • Commerzbank Aktiengesellschaft first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 28 quarters.
  • Commerzbank Aktiengesellschaft's Alexion Pharmaceuticals position peaked at $23.9M in Q2 2015.
  • 707 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2020.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2020, filed 21 Jul 2020.